
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Toward a Shigella Vaccine: Opportunities and Challenges to Fight an Antimicrobial-Resistant Pathogen
Maria Michelina Raso, Vanessa Arato, Gianmarco Gasperini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4649-4649
Open Access | Times Cited: 22
Maria Michelina Raso, Vanessa Arato, Gianmarco Gasperini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4649-4649
Open Access | Times Cited: 22
Showing 22 citing articles:
Vaccines and Monoclonal Antibodies as Alternative Strategies to Antibiotics to Fight Antimicrobial Resistance
Chiara La Guidara, Roberto Adamo, Claudia Sala, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5487-5487
Open Access | Times Cited: 9
Chiara La Guidara, Roberto Adamo, Claudia Sala, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5487-5487
Open Access | Times Cited: 9
Safety and immunogenicity of a 4-component GMMA-based Shigella vaccine in healthy European adults: Stage 1 of a randomized, controlled phase I/II clinical trial
Isabel Leroux‐Roels, Cathy Maes, Francesca Mancini, et al.
The Journal of Infectious Diseases (2024)
Open Access | Times Cited: 6
Isabel Leroux‐Roels, Cathy Maes, Francesca Mancini, et al.
The Journal of Infectious Diseases (2024)
Open Access | Times Cited: 6
Anti-Shigella and antioxidant-based screening of some Cameroonian medicinal plants, UHPLC-LIT-MS/MS fingerprints, and prediction of pharmacokinetic and drug-likeness properties of identified chemicals.
Yanick Kevin Dongmo Melogmo, Mariscal Brice Tchatat Tali, Darline Dize, et al.
Journal of Ethnopharmacology (2024), pp. 117788-117788
Closed Access | Times Cited: 4
Yanick Kevin Dongmo Melogmo, Mariscal Brice Tchatat Tali, Darline Dize, et al.
Journal of Ethnopharmacology (2024), pp. 117788-117788
Closed Access | Times Cited: 4
Population Enumeration and Household Utilization Survey Methods in the Enterics for Global Health (EFGH): Shigella Surveillance Study
Ryan Dodd, Alex O Awuor, Paul F. Garcia Bardales, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. Supplement_1, pp. S17-S24
Open Access | Times Cited: 4
Ryan Dodd, Alex O Awuor, Paul F. Garcia Bardales, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. Supplement_1, pp. S17-S24
Open Access | Times Cited: 4
Salmonella Typhimurium derived OMV nanoparticle displaying mixed heterologous O-antigens confers immunogenicity and protection against STEC infections in mice
Xiaoping Bian, Yaolin Chen, Wenjin Zhang, et al.
Microbial Cell Factories (2025) Vol. 24, Iss. 1
Open Access
Xiaoping Bian, Yaolin Chen, Wenjin Zhang, et al.
Microbial Cell Factories (2025) Vol. 24, Iss. 1
Open Access
Shigellosis in an Urban Slum in Kenya: Risk factors and antimicrobial resistance
Beatrice Ongadi, Asma Binte Aziz, Cecilia Mbae, et al.
Open Forum Infectious Diseases (2025) Vol. 12, Iss. 2
Open Access
Beatrice Ongadi, Asma Binte Aziz, Cecilia Mbae, et al.
Open Forum Infectious Diseases (2025) Vol. 12, Iss. 2
Open Access
A three-dimensional high throughput assay identifies novel antibacterial molecules with activity against intracellular Shigella
Voong Vinh Phat, Andrew Lim, Cristina De Cozar-Gallardo, et al.
Research Square (Research Square) (2025)
Closed Access
Voong Vinh Phat, Andrew Lim, Cristina De Cozar-Gallardo, et al.
Research Square (Research Square) (2025)
Closed Access
A Candidate Ac3-S-LPS Vaccine Against S. flexneri 1b, 2a, 3a, 6, and Y Activates Long-Lived Systemic and Mucosal Immune Responses in Healthy Volunteers: Results of an Open-Label, Randomized 2 Clinical Trial
Vladimir A. Ledov, Victor V. Romanenko, M.E. Golovina, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 209-209
Open Access
Vladimir A. Ledov, Victor V. Romanenko, M.E. Golovina, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 209-209
Open Access
Burden of Shigella Among Children with Diarrhea in the Americas: A Systematic Review and Meta-Analysis
Maya Lubeck-Schricker, Andrea C Rivas-Nieto, Jennifer Jacqueline Rosauer, et al.
(2025)
Closed Access
Maya Lubeck-Schricker, Andrea C Rivas-Nieto, Jennifer Jacqueline Rosauer, et al.
(2025)
Closed Access
Development of a Novel mRNA Vaccine Against Shigella Pathotypes Causing Widespread Shigellosis Endemic: An In-Silico Immunoinformatic Approach
Abdur Razzak, Otun Saha, Khandokar Fahmida Sultana, et al.
Bioinformatics and Biology Insights (2025) Vol. 19
Open Access
Abdur Razzak, Otun Saha, Khandokar Fahmida Sultana, et al.
Bioinformatics and Biology Insights (2025) Vol. 19
Open Access
Protein-specific immune response elicited by the Shigella sonnei 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to Shigella
Arlo Randall, Valentino Conti, Usman Nakakana, et al.
mSphere (2025)
Open Access
Arlo Randall, Valentino Conti, Usman Nakakana, et al.
mSphere (2025)
Open Access
Innovative strategies in the fight against bacterial infections: Phage therapy, nanotechnology, and new antimicrobial agents for multidrug-resistant pathogens
Rahul Kashyap, Sumeet K. Tiwari, Bhupendra G. Prajapati
Results in Chemistry (2025), pp. 102304-102304
Open Access
Rahul Kashyap, Sumeet K. Tiwari, Bhupendra G. Prajapati
Results in Chemistry (2025), pp. 102304-102304
Open Access
Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccine
Valentino Conti, Omar Rossi, Kristen A. Clarkson, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Valentino Conti, Omar Rossi, Kristen A. Clarkson, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Designing a multi-epitope vaccine against Shigella dysenteriae using immuno-informatics approach
Hurria Qureshi, Amina Basheer, Muhammad Faheem, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 2
Hurria Qureshi, Amina Basheer, Muhammad Faheem, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 2
Immunization of BALB/c Mice against Shigella sonnei Using a Multiepitope Protein Vaccine through Intranasal and Subcutaneous Administration
Shabnam Akhgar, Shamsi Noorpisheh Ghadimi, Ibrahim Farhani, et al.
Iranian Journal of Allergy Asthma and Immunology (2024)
Open Access | Times Cited: 1
Shabnam Akhgar, Shamsi Noorpisheh Ghadimi, Ibrahim Farhani, et al.
Iranian Journal of Allergy Asthma and Immunology (2024)
Open Access | Times Cited: 1
Shigella sonnei: epidemiology, evolution, pathogenesis, resistance and host interactions
Timothy A. Scott, Kate S. Baker, Caroline Trotter, et al.
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 1
Timothy A. Scott, Kate S. Baker, Caroline Trotter, et al.
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 1
Crude Extracts from Diospyros Gilletii Stem Bark Attenuates Shigella Flexneri-Induced Diarrhoea in Mice
Bijou-Lafortune Noumboue Kouamou, Boniface Pone Kamdem, Vincent Ngouana, et al.
(2024)
Closed Access
Bijou-Lafortune Noumboue Kouamou, Boniface Pone Kamdem, Vincent Ngouana, et al.
(2024)
Closed Access
Whole genome sequencing and antimicrobial resistance among clinical isolates of Shigella sonnei in Addis Ababa, Ethiopia
Basha Ayele, Adane Mihret, Zeleke Mekonnen, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0313310-e0313310
Open Access
Basha Ayele, Adane Mihret, Zeleke Mekonnen, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0313310-e0313310
Open Access
Phytochemical Analysis and Antimicrobial Activity of Terminalia bellirica (Gaertn.) Roxb. and Terminalia chebula Retz. Fruit Extracts Against Gastrointestinal Pathogens: Enhancing Antibiotic Efficacy
Gagan Tiwana, Ian Edwin Cock, Matthew James Cheesman
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2664-2664
Open Access
Gagan Tiwana, Ian Edwin Cock, Matthew James Cheesman
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2664-2664
Open Access
Comparison of Shigella GMMA and glycoconjugate four-component formulations in animals
Roberta Di Benedetto, Francesca Mancini, Valentina Caradonna, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 1
Roberta Di Benedetto, Francesca Mancini, Valentina Caradonna, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 1
Refining Immunogenicity through Intradermal Delivery of Outer Membrane Vesicles against Shigella flexneri in Mice
Yadira Pastor, Alba Calvo, Josune Salvador-Erro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16910-16910
Open Access | Times Cited: 1
Yadira Pastor, Alba Calvo, Josune Salvador-Erro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16910-16910
Open Access | Times Cited: 1
Towards establishing a correlate of protection against shigellosis: assessing immunological endpoints across immune responses to the Shigella sonnei 1790GAHB GMMA investigational vaccine
Usman Nakakana, Valentino Conti, Omar Rossi, et al.
Research Square (Research Square) (2023)
Open Access
Usman Nakakana, Valentino Conti, Omar Rossi, et al.
Research Square (Research Square) (2023)
Open Access
Towards establishing correlates of protection against shigellosis: assessing immunological endpoints across immune responses to the Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) candidate vaccine (1790GAHB).
Usman Nakakana, Valentino Conti, Omar Rossi, et al.
Research Square (Research Square) (2023)
Open Access
Usman Nakakana, Valentino Conti, Omar Rossi, et al.
Research Square (Research Square) (2023)
Open Access